🟢 Tenaya Therapeutics is trading 5% up today as biotech and broader markets rise

Tenaya Therapeutics is trading at $0.38, up 5.41%, with broader biotech and market strength the likeliest explanation, though no source directly attributes the gain to it.

• Biotech ETF XBI is up 2.13%, while major U.S. indices are also higher.
• No fresh company-specific announcement clearly explains the November 4 move.
• A November 4 article mentions the existing Alnylam collaboration, not a new catalyst.